Rekvina Laboratories Limited (BOM:526075)
36.00
0.00 (0.00%)
At close: Jul 8, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 217.01 million as of July 8, 2026. Its market cap has increased by 554.55% in one year.
Market Cap
217.01M
Enterprise Value
231.58M
Revenue
12.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
Market Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 217.01M, a decrease of -51.08%. That is a compound annual growth rate of -5.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 217.01M | 700.00% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Welcure Drugs and Pharmaceuticals | 321.34M |
| Deccan Health Care | 314.60M |
| Panjon | 300.72M |
| Gujarat Terce Laboratories | 264.90M |
| Hamps Bio | 228.69M |
| Cian Healthcare | 206.50M |
| Add-Shop E-Retail | 194.23M |
| Desh Rakshak Aushdhalaya | 185.71M |